The number of women in the present study with a first-degree family history of breast cancer who tested negative for BRCA1/BRCA2 mutations (71 cases, 27 controls) does not offer adequate power to detect differences in the frequency of CHEK2 variants within this stratification. The gene discussed is BRCA2; the disease is breast cancer.